Amyloidosis Treatment at the University of Colorado Cancer Center
Amyloidosis can be a symptom of myeloma (secondary) or it can be primary, with no evidence of myeloma.
We Specialize in Blood Cancers
There are more than 100 different types of cancer. To ensure that we are always leading care at the cutting edge, the CU Cancer Center has expert teams that each specialize in a small number of different cancer types. Because we are sub-specialized in blood cancers, including lymphomas, leukemia and multiple myelomas, we have treated the most common and the rarest types of cancer.
Myeloma and Amyloidosis at a Glance
is a type of cancer in the plasma cells, which are immune system cells in the bone marrow. Some people have no symptoms, but others may have problems such as anemia, elevated blood calcium, kidney damage, bone disease, amyloidosis or frequent infections.
Amyloidosis is the name for a group of diseases in which organ systems in the body accumulate deposits of abnormal proteins known as amyloid. Although amyloidosis is not cancer, it is a blood disorder that can be disabling or life-threatening. Most commonly, it affects the kidney, heart, liver and autonomic or peripheral nerves.
- There are 69,598 people living with or in remission from myeloma in the U.S.
- Approximately 20,180 people are diagnosed with myeloma in the United States each year.
- The median age at diagnosis is 70 years; myeloma rarely occurs in people under age 45.
- From 1975 to 2007, the incidence of myeloma increased by 11.4 percent.
- The incidence of myeloma among African Americans was almost 105 percent greater than myeloma incidence among Caucasians in 2007.
- About 1,200 to 3,200 new amyloidosis cases are diagnosed nationwide each year.
Source: The Leukemia and Lymphoma Society